Pellegrini–Stieda syndrome
Pellegrini–Stieda syndrome is a medical condition characterized by pain and stiffness in the knee. It is caused by calcification at the site of a previous injury to the medial collateral ligament of the knee. The syndrome is named after Italian surgeon Augusto Pellegrini and German radiologist Alban Köhler.
Symptoms[edit | edit source]
The primary symptom of Pellegrini–Stieda syndrome is pain in the knee, particularly on the inner side. This pain is often accompanied by stiffness and a reduced range of motion. The pain may be exacerbated by physical activity, particularly activities that involve bending or twisting the knee.
Causes[edit | edit source]
Pellegrini–Stieda syndrome is caused by calcification at the site of a previous injury to the medial collateral ligament of the knee. This calcification is thought to result from a process called heterotopic ossification, in which bone tissue forms in places where it should not. The exact cause of this process is not fully understood, but it is thought to be related to inflammation and tissue damage.
Diagnosis[edit | edit source]
The diagnosis of Pellegrini–Stieda syndrome is typically made based on the patient's symptoms and the results of imaging studies. X-rays of the knee can often reveal the characteristic calcification at the site of the medial collateral ligament. In some cases, other imaging studies such as MRI or CT scans may be used to confirm the diagnosis and rule out other conditions.
Treatment[edit | edit source]
The treatment of Pellegrini–Stieda syndrome typically involves a combination of conservative measures and, in some cases, surgery. Conservative measures may include rest, physical therapy, and the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. If these measures are not effective, surgery may be considered to remove the calcified tissue.
See also[edit | edit source]
Pellegrini–Stieda syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD